Categories: News

Bossjob’s Twin Engine Strategy Revolutionizes Talent Acquisition at Tokyo WebX Summit

TOKYO, Aug. 20, 2025 /PRNewswire/ — Bossjob, Asia’s premier Web3 talent ecosystem, has confirmed its role as a GOLD partner at the Tokyo WebX Summit on August 25–26. As the only provider offering a comprehensive talent solution that combines an AI-driven recruitment platform with top-tier headhunting, it will debut its “dual-engine drive” strategy to the Asian market at this prestigious event. Bossjob will also announce its participation in Token2049, Asia’s leading digital asset summit, taking place in Singapore this October.

- Advertisement -

The Tokyo WebX Summit presents Bossjob with a unique opportunity to demonstrate how their dual-engine approach, combining AI technology and elite headhunting services, delivers a holistic solution for Web3 enterprises, from talent identification and precise matching to seamless onboarding.

- Advertisement -

Engine One: AI Recruitment Platform Paving the Web3 Talent Expressway

- Advertisement -

With a network comprising over 1000 Web3 companies, the platform serves as a self-reinforcing ecosystem, leveraging the following key advantages:

- Advertisement -
  • Data-driven efficiency: The platform’s AI system automatically captures on-chain developer activities (including GitHub, Dune, and smart contract engagements) for every job posting, continuously enriching its extensive talent pool of over 100,000 individuals and meticulously managing 87 key competency dimensions.
  • Dynamic model optimization: To address the rapidly evolving skill requirements in the Web3 domain, such as sudden surges in demand for Move language expertise, the platform can swiftly recalibrate its job matching model within 72 hours, ensuring a consistent matching accuracy of over 92%.

Engine Two: Elite Headhunting Overcoming High Barriers in the Talent War

- Advertisement -

In just 16 months, Bossjob’s headhunting division has placed top talent in 30+ leading Web3 projects with tailored solutions:

- Advertisement -
  • Extensive intelligence network: Tapping into 200+ core developer Discord communities to precisely track target talents’ activities and skills.
  • Rapid talent delivery: Secured a Rust-proficient Security Audit Director with Japan’s FSA compliance expertise for a top-3 global crypto exchange in just 7 days.
  • Retention-focused approach: Offers anti-poaching measures and a unique compensation hedging model to protect against market volatility, ensuring long-term talent stability and company security.

Andy, CEO of Bossjob in Web3, highlighted, “In just 16 months, our headhunting business has delivered efficiently by transforming our platform’s talent pool of over 20,000 individuals into a dynamic ‘live ammunition depot,’ paving the way for future connections and empowering companies to dominate the Asian Web3 talent landscape.”

- Advertisement -

For more information, please visit https://go.bossjob.com/web3_7xJ9kL2P

- Advertisement -

 

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/bossjobs-twin-engine-strategy-revolutionizes-talent-acquisition-at-tokyo-webx-summit-302533286.html

- Advertisement -

Recent Posts

Ocular Therapeutix Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: Ocular Therapeutix, Inc. BEDFORD, Mass., Feb. 06, 2026…

6 hours ago

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

February 06, 2026 16:01 ET  | Source: NewAmsterdam Pharma N.V. NAARDEN, The Netherlands and MIAMI,…

6 hours ago

Novartis breaks ground on new global Biomedical Research center in San Diego to accelerate drug discovery

New facility will enable end‑to‑end discovery across key disease areas and technology platforms, joining existing…

6 hours ago

The Ministry of Finance and the International Monetary Fund to launch tomorrow the second edition of the AlUla Conference for Emerging Market Economies

AlUla, Saudi Arabia, Feb. 7, 2026 /PRNewswire/ -- The second edition of the AlUla Conference…

6 hours ago

Roches fenebrutinib is the first investigational medicine in over a decade that reduces disability progression in primary progressive multiple sclerosis (PPMS)

Late-breaking Phase III FENtrepid results presented at ACTRIMS show investigational fenebrutinib met its primary endpoint…

6 hours ago

Lexicon Announces Closing of Approximately $94.6 Million Public Offering and Concurrent Private Placement

February 06, 2026 17:17 ET  | Source: Lexicon Pharmaceuticals, Inc. THE WOODLANDS, Texas, Feb. 06,…

6 hours ago